GE HealthCare Technologies Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 17.59B | 18.34B | 19.55B | 19.67B | 20.63B | 4.8% | |
| Cost of Revenue | (10.41B) | (11.16B) | (11.63B) | (11.47B) | (12.38B) | 7.9% | |
Gross Profit | 7.17B | 7.18B | 7.92B | 8.21B | 8.25B | 0.5% | |
| Operating Expenses | |||||||
| Research & Development | (816.00M) | (1.03B) | (1.21B) | (1.31B) | (1.26B) | -3.9% | |
| Selling, General & Administrative | (3.56B) | (3.63B) | (4.28B) | (4.27B) | (4.22B) | -1.0% | |
| Depreciation & Amortization | (625.00M) | (633.00M) | (610.00M) | (580.00M) | (578.00M) | -0.3% | |
Operating Income (EBIT) | 2.79B | 2.52B | 2.44B | 2.63B | 2.76B | 5.2% | |
| Non-Operating Items | |||||||
| Interest Income | 34.00M | — | 26.00M | — | — | — | |
| Interest Expense | (40.00M) | (86.00M) | (542.00M) | (505.00M) | (450.00M) | -10.9% | |
| Other Income/Expenses (Net) | 80.00M | -10.00M | -74.00M | -44.00M | 6.00M | -113.6% | |
Income Before Tax | 2.88B | 2.51B | 2.36B | 2.58B | 2.77B | 7.2% | |
| Income Tax Expense | (600.00M) | (563.00M) | (743.00M) | (531.00M) | (614.00M) | 15.6% | |
Net Income | 2.25B | 1.92B | 1.57B | 1.99B | 2.08B | 4.6% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $5 | $4 | $3 | $4 | $5 | 4.3% | |
| Weighted Avg Shares Outstanding | 454.71M | 453.93M | 455.00M | 456.00M | 456.52M | 0.1% | |
| Weighted Avg Shares Outstanding (Diluted) | 454.71M | 453.93M | 458.00M | 459.00M | 460.27M | 0.3% | |
EBITDA | 3.54B | 3.17B | 3.51B | 3.67B | 3.79B | 3.2% |
Explore GEHC
GEHC in the Healthcare
Large Cap